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Abstract 
This article investigates the effects of commercially available artificial (aspartame, saccharin, 
sucralose) and natural sweeteners (brown sugar, white sugar, molasses) on the immune 
system. Human whole blood cultures were incubated with various sweeteners and 
stimulated in vitro with either phytohemagglutinin or endotoxin. Harvested supernatants 
were screened for cytotoxicity and cytokine release. Results showed that none of the 
artificial or natural sweeteners proved to be cytotoxic, indicating that no cell death was 
induced in vitro. The natural sweetener, sugar cane molasses (10 ug=mL), enhanced levels 
of the inflammatory biomarker IL-6 while all artificial sweeteners (10 ug=mL) revealed a 
suppressive effect on IL-6 secretion (P < 0.001). Exposure of blood cells to sucralose-
containing sweeteners under stimulatory conditions reduced levels of the biomarker of 
humoral immunity, Interleukin-10 (P < 0.001). The cumulative suppression of 
Interleukin-6 and Interleukin-10 levels induced by sucralose may contribute to the 
inability in mounting an effective humoral response when posed with an exogenous threat. 
 
Introduction 
The desire for sweet tasting food is inherent and characteristic of the human 
population. Prehistoric man satisfied his need for sweet taste through the 
intake of certain fruits and vegetables. Years later, through the 
advancement in food technology, refined sugar was made accessible to 
people at low cost. This sparked an increase in the use of sugar 
worldwide.[1] 
 
Today, there is an extensive choice of sweeteners available to the consumer. 
These sweeteners can be categorised into either nutritive (natural 
sweeteners)   or   non-nutritive   sweeteners   (artificially   manufactured 
sweeteners). Sugar cane molasses is an example of a popular, natural sweetener 
rich in sucrose and is the by-product of the sugar refinement process.[2] Dating 
back to the 19th century, molasses has been used widely in livestock and poultry 
feeds.[3] Today, molasses is increasingly being used as a flavor enhancer, has been 
substituted as a sweetener, and used as a preservative in jams and jellies.[4] 
Anecdotal reports also suggest that molasses may be used as a supplement in the 
human diet to improve conditions such as anaemia, colds, coughs, earaches, 
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arthritis, ulcers, hair damage, eczema, high blood pressure, dermatitis, 
constipation, varicose veins, nerve damage, and bladder problems.[4–6] 
 
Although molasses has been associated with various health benefits, there are 
also reports that suggest the inclusion of molasses in the diet of livestock may induce 
certain metabolic diseases. Such diseases include molasses toxicity, urea toxicity, 
and bloat which may occur as a result of molasses being used as a supplement 
(vehicle for urea) or as the basis of livestock feed.[7] Molasses toxicity is defined 
as a condition affecting cattle or sheep fed high molasses diets with limited 
forage.[8] Effected animals suffer from symptoms similar to that of cerebro-ortical 
necrosis or polioencephalomalacia. Bloat is a condition characterised by the 
retention of gas in the rumen and occurs in most animal feeding  systems. 
However, this disease appears to  be recurrent in diets consisting of 
carbohydrates supplied by unrefined sugar or maize grain that has little or no 
fiber, yet is easily digestible.[7] 
 
Sugar or sucrose consumption has been associated with dental caries, obesity, 
and chronic diseases linked to obesity such as cancer, diabetes, and heart 
disease. As a result, this created a demand for the development of alternate 
sweeteners, which offer a low-calorie intake.[1] The manufacture of artificial 
sweeteners by the food industry, promised consumers the sweetness of sugar 
without the calories.[9] Diabetic patients and individuals wanting to control their 
weight have access to these products that allow them the pleasure of a sweet-
tasting treat without adverse health effects.[1] These alternate sweeteners are 
used extensively as additives in food, beverages, confectionary, and in the 
pharmaceutical sector. Common types of artificial sweeteners include aspartame, 
acesulfame-K, cyclamate, neotame, sucralose, and saccharin.[10] Although 
artificial sweeteners have been welcomed into the food industry for its beneficial 
uses, some studies have found correlations between their use and illnesses such as 
cancers, hepatotoxicity, headaches, allergies, seizures, diarrhoea, and low birth 
weight.[9] 
 
Commercially available saccharin is almost 300–500 times  sweeter than 
sucrose.[11] This artificial sweetener is probably one of the most scrupulously 
researched sweeteners since its discovery, with much of the focus pertaining to its 
potential role  in  bladder  cancer.[2]  There  have been   approximately   20   
experimental  groups   that  have   independently investigated the effect of elevated 
doses of saccharin in one-generation rats. Results from these studies show that the 
majority of these groups could not positively associate saccharin-fed rats with the 
development of neoplasias. Although the positive control group did reflect an 
increased incidence of bladder cancer, this result was questionable since rats that 
were used in the studies were regularly infected with the bladder parasite 
Trichosomoides crassicanda. In two-generation rat studies, results show almost 
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consistently that rats fed on saccharin diets and born of saccharin-fed parents 
had an increased risk of developing bladder cancer.[12] 
 
Aspartame first came into existence in 1965 and has been packaged under 
labels such as Nutra sweetTM, CanderelTM, and EqualTM.[13,14] In the body, 
aspartame is hydrolyzed into its components, namely, phenylalanine, aspartic 
acid, and methanol. Research has focused on the plasma levels of these 
products within the human body. These studies have revealed both potentially 
normal conditions of use and adverse effects arising from the consumption of 
aspartame.[15] In 1996, Olney and colleagues published a contentious paper 
suggesting that a link between the surge in brain tumors since 1980 and the 
introduction of aspartame into the food industry existed. They further 
supported their hypothesis by referring to an FDA experiment in which 12 out of 
320 Sprague-Dawley rats developed malignant brain tumors following long-
term, aspartame ingestion. This hypothesis raised much concern amongst the 
general public but was also profoundly criticized by many scientists.[12,16] 
 
Sucralose has been branded under the name SplendaTM and has a wide variety of 
uses in the food industry.[9] The production of sucralose involves the replacement 
of three chlorine atoms for three hydroxyl groups in sucrose. The safety 
concern of this compound arises because of the existence of three chlorine atoms, 
which make it an organochloride. Organochlorides such as pesticides and dioxins 
have been largely reported as being carcinogenic. Hence, sucralose has also been 
subjected to toxicity screening.[10] 
 
Since their existence, the usage of natural and artificial sweeteners has been quite 
controversial. Their implication in various diseases has raised much 
questionability with respect to their safe use.[9] Therefore, it is necessary that 
these sweeteners be subjected to toxicity screening to determine their effects on 
human health. 
 
This article aims to determine the potential modulatory effects of both natural 
and artificial sweeteners on the immune system. Human whole blood cultures 
(hWBC) were used as a model system to determine the impact of sweeteners 
on immune function. Lactate dehydrogenase release was used as a biomarker for 
cytotoxicity. Interleukin-6 (IL-6) was used as a biomarker of the inflammatory 
response, Interleukin-10 (IL-10) as a biomarker of humoral immunity, and 
Interferon-gamma (IFNg) as a biomarker of cell-mediated immunity. 
 
The immune system is an intricate and interactive network that comprises of 
various components. This system primarily functions in defense against 
foreign or antigenic particles entering the body as well as protecting the 
integrity of the host against attack and disease triggered by pathogenic 
organisms.[17] The human immune response consists of two branches, 
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which include innate and acquired immunity. Phagocytic cells and cellular 
components such as interferons make up the innate immune response, 
which acts as the first line of defense against pathogens.[18,19] The 
acquired immune response consists of two branches, namely cell-
mediated and humoral immunity. Both B and T lymphocytes function in 
recognizing and destroying invading pathogens and are the main cells 
involved in this form of immunity. The acquired immune response 
requires prior sensitization to an antigen whereas the innate immune 
response is not dependent on exposure to an antigen.[18] 
 
Research in toxicology has shown that the immune system is a target for 
various chemicals and that a toxicant has the ability to affect a constituent of 
the immune system at any level.[20,21] Immunotoxicology can be defined as 
‘the study of adverse effects of foreign substances also referred to as 
xenobiotics on the immune system, which results in harmful alterations in 
the host responses and ultimately leads to the increased risk to infectious 
disease.’[20] A chemical insult to the immune system encompasses a variety of 
effects that include enhancement or suppression of the immune 
response.[22] A decreased immune response may be associated with an 
increase in the incidence, time-span, severity, or result of an attack by an 
invading pathogen. An enhanced immune response may be either 
beneficial or detrimental to the host since it may further increase the 
immune response to a disease or neutralise the effects of autoimmunity or 
hypersensitivity reactions.[17] Industralized countries are experiencing a 
significant increase in diseases that can be associated with a malfunction in 
the immune system.[22] Thus, the immunotoxicity of drugs and various 
compounds, particularly those that we are exposed to regularly, are 
progressively being identified as potential hazards. 
 
Experimental methods 
Principle of the Procedure 
In this article, human blood was treated with the B-cell mitogen, 
lipopolysaccharide (LPS), and the T cell mitogen, phytohemagglutinin (PHA). LPS 
stimulates an inflammatory response and initiates the release of IL-6 from 
monocytes and B lymphocytes.[24] PHA was used to stimulate the cell mediated 
and humoral immune pathways, initiating the release of IFNg and IL-10 from T 
lymphocytes. Cytokine production was measured inthe supernatants, following 
incubation with or without the test compound. Cytokines  were  quantified  
using  Enzyme-Linked  Immunosorbent  Assays (ELISAs).  
 
Whole Blood Cytokine Assays 
Blood was obtained from healthy human male donors and was stored at ambient 
room temperature. Consent was obtained from all participants and all 
procedures were conducted in accordance with guidelines of the ethics 
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committee at the University of the Western Cape. Blood samples were collected 
in 10 mL citrate-containing vacuum tubes by venipuncture and used within 8 hr 
of collection. All procedures were performed under sterile conditions. Whole 
blood was diluted 1:10 with RPMI-1640 (Sigma-Aldrich Inc., St. Louis, MO, 
USA) before being stimulated with a mitogen or remaining unstimulated. 
 
Natural (sugar cane molasses, white sugar, and brown sugar) and artificial 
sweeteners (CanderelTM, EqualTM, NatreenTM, SweetexTM, SplendaTM, and 
SwheetTM) that are commercially available were used for all experiments. The 
artificial sweeteners used, may be classified into their relevant groups based on 
their principal ingredient. The brands CanderelTM and EqualTM consist of 
aspartame, NatreenTM and SweetexTM are composed of saccharin and 
SplendaTM and SwheetTM  
 
The Effects of Natural and Artificial Sweeteners on Stimulated and 
Unstimulated hWBC 
Diluted whole blood remained unstimulated or stimulated without mitogens (to 
give a final concentration of 10 ng=mL LPS and 16 ug=mL PHA).  Both  
commercially  available  natural  (molasses,  white  sugar,  and brown sugar) and 
artificial sweeteners (CanderelTM, EqualTM, NatreenTM, SweetexTM, 
SplendaTM, and SwheetTM) were diluted in distilled water and used at a 
concentration of 10 ug=mL. LPS-stimulated and unstimulated blood (500 
mL=well) were added to 48-well culture plates and incubated at 37oC in the 
presence or absence of sweeteners (5 mL=well) for 18 hr. PHA stimulated and 
unstimulated blood (500 mL=well) were added to 48-well culture plates and 
incubated at 37oC in the presence or absence of sweeteners (5 mL=well) for 48 
hr. Control wells consisted of stimulated or unstimulated cells cultured in 
medium alone. All samples were plated in triplicate. At the end of the incubation 
period, the culture supernatants harvested from the LPS stimulated cultures 
were assayed for IL-6 and lactate dehydrogenase activity (LDH), while the PHA 
stimulated supernatants were assayed for IFNg and IL-10 synthesis. 
 
Cytotoxicity 
A commercially available chromogenic, lactate dehydrogenase assay kit was 
used to analyze all samples (Roche Diagnostics, Indianapolis, IN, USA). The 
assay was performed in accordance with the manufacturer’s guidelines. 
 
Cytokine Analysis 
The concentrations of cytokine biomarkers, i.e., IL-6, IL-10, and IFNg were all 
determined using commercially available ELISA kits (e-Bioscience, San Diego, CA, 
USA). All cytokine assays were conducted according to instructions provided. 
Assays were performed using 96-well plates (Nunc1, Serving Life Science, Vernon 
Hills, IL, USA) and cytokine levels were expressed as pg=mL. 
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Statistical Analysis 
All data was statistically analysed using one-way ANOVA using SigmaStat software 
(Systat Software Inc., Chicago, IL, USA). The Dunnett’s test was specifically used to 
determine the  differences  between  the  sample  and the control groups. All 
cytokine assays were conducted in triplicate to avoid statistical errors. Results were 
expressed in terms of the mean ± standard error of the mean (SEM). 
 
Results and discussion 
The Effects of Artificial and Natural Sweeteners on the Immune System 
Cytotoxicity of Natural and Artificial Sweeteners 
A standard curve was generated to determine the percentage toxicity of all 
samples. Results showed that percentage toxicity obtained for both stimulated 
and unstimulated cultures incubated with the various sweeteners, were similar 
to that of the distilled water control. Hence, none of the natural or artificial 
sweeteners proved to be cytotoxic (data not shown). 
 
The Effects of Natural and Artificial Sweeteners on Endotoxin-Stimulated and 
Unstimulated hWBC 
IL-6 is a pleiotrophic cytokine and plays an important role in stimulating B 
cells to synthesise antibodies. IL-6 is also a sensitive biomarker used to 
investigate inflammatory activity.[25] A significant effect on IL-6 
concentration was observed when comparing individual artificial sweeteners 
and the natural sweetener, sugar cane molasses to the distilled water control 
under stimulated conditions (P < 0.001) (Figure 1). In the presence of LPS, all 
artificial sweeteners suppressed the secretion of IL-6, while sugar cane molasses 
enhanced the secretion of IL-6 (P < 0.001) in vitro. This result may be 
interpreted as the inability of artificial sweeteners to produce an effective 
inflammatory defense when challenged with the bacterial pathogen endotoxin. On 
the contrary, sugar cane molasses increased inflammatory activity and produces an 
efficient immune response when posed with a threat. Normally, infection or injury 
caused to the body initiates the synthesis of pro-inflammatory cytokines and the 
elevated levels of these cytokines are essential for recovery.[26] The increased 
inflammatory response produced by molasses under unstimulated conditions may 
therefore initiate a competent immune defense mounted against invading 
pathogens on the healthy immune system. However, this form of ‘‘hyperstimulation’’ 
may also be associated with hypersensitivity reactions, which are known to 
adversely affect the health of an individual. The ability of molasses  to  enhance  
inflammatory  activity  in  vitro  is  supported  by  earlier data.[27] As previously 
stated, the inflammatory potential of molasses may prove to be therapeutic 
when administered to patients suffering from immunosuppressive illnesses 
such as cancer and AIDS.[27] 
 
In the absence of the stimulus LPS, all artificial sweeteners including the natural 
sweeteners, brown and white sugar showed no effect on IL-6 synthesis when 
compared to the distilled water control (P > 0.001). However, IL-6 levels of 
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unstimulated cultures exposed to sugar cane molasses exceeded that of the 
control (P < 0.001). 
 
 
 
FIGURE 1 The inflammatory activity of artificial and natural sweeteners in LPS stimulated and 
unstimulated whole blood cultures. Data is expressed as the mean ± standard error of the mean of three 
replicates  (n = 21).  An  asterisk  (*)  indicates  statistical  difference  to  the  distilled  water  control 
(P < 0.001). Stimulated = ■; unstimulated = □. 
 
The Effects of Natural and Artificial Sweeteners on PHA-Stimulated and 
Unstimulated hWBC 
Certain infections can cause chronic or persistent inflammation that 
ultimately ends in pathological effects such as cancer, cardiovascular disease, 
age-related chronic diseases and Type 2 diabetes.[26] The level of cytokine 
synthesis and the balance between inflammatory cytokines vs. anti-
inflammatory cytokines determines the time-span as well as the end-result of 
the immune response.[28] 
 
Results showed that the artificial sweetener, sucralose branded under the  
names  of  SplendaTM  and  SwheetTM  significantly  reduced the levels of 
the anti-inflammatory cytokine, IL-10 under stimulated conditions (P < 
0.001) (Figure 2). The decrease of IL-10 levels by sucralose suggests a 
diminished humoral immune response against extracellular pathogens 
such as bacteria, fungi and yeast.[29] The cumulative effect of reduced IL-
6 and IL-10 synthesis induced by sucralose, further suggests the suppression 
of antibody synthesis against infective extracellular pathogens. 
 
The comparison of all artificial and natural sweeteners to the distilled water 
control under unstimulated conditions showed no significant effect on IL-6 
or IL-10 synthesis (Figures 1 and 2). The Th1 cytokine, IFNg, enhances the 
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activation of macrophages, antibody-dependent cellular cytotoxicity as well 
as the complement pathway. This form of immune protection functions in 
defense against intracellular pathogens and any disruption caused to these 
cells may lead to tissue damage in the host.[30] The comparison of all 
sweeteners to the control cultures under both stimulated and unstimulated 
conditions showed that none of the sweeteners had an effect on IFNg synthesis 
(P > 0.05) (Figure 3). Hence, none of the sweeteners had an impact on cell-
mediated immunity. 
 
 
FIGURE 2 IL-10 synthesis by PHA stimulated and unstimulated WBCs incubated with artificial or 
natural sweeteners. Data is expressed as the mean ± standard error of the mean of three replicates (n ¼ 
21). An asterisk (*) indicates the statistical difference to the distilled water control (P < 0.001). Stimulated 
= ■;  unstimulated = □. 
 
 
 
https://repository.uwc.ac.za/
9 
 
 
 
FIGURE 3 IFNg synthesis by PHA stimulated and unstimulated WBCs incubated with artificial or natural 
sweeteners. Data is expressed as the mean ± standard error of the mean of three replicates (n = 21). An asterisk (*) 
indicates the statistical difference to the distilled water control (P > 0.05). Stimulated = ■; unstimulated = □. 
 
Conclusion 
The current article shows that both artificial and natural sweeteners are not 
cytotoxic, however they do have an impact on certain cellular pathways. All artificial 
sweeteners containing aspartame, saccharin and sucralose appear to inhibit 
inflammatory activity in vitro. Sucralose-containing sweeteners may potentially 
reduce humoral immunity thus increasing susceptibility of host defense against 
extracellular pathogens. On the contrary, the inflammatory potential of the 
nutritive sweetener, sugar cane molasses may be favorable in defense against 
infective pathogens. Although certain sweeteners have displayed 
immunomodulatory effects in vitro, further studies  on  artificial  and  natural  
sweeteners  are  required  to  determine  if these sweeteners display similar effects in 
vivo. 
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